Becton Dickinson and Company (BDX) - Total Liabilities
Based on the latest financial reports, Becton Dickinson and Company (BDX) has total liabilities worth $26.70 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Becton Dickinson and Company - Total Liabilities Trend (1985–2025)
This chart illustrates how Becton Dickinson and Company's total liabilities have evolved over time, based on quarterly financial data. See Becton Dickinson and Company current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Becton Dickinson and Company Competitors by Total Liabilities
The table below lists competitors of Becton Dickinson and Company ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Skandinaviska Enskilda Banken AB (publ)
ST:SEB-A
|
Sweden | Skr3.44 Trillion |
|
ArcelorMittal SA
AS:MT
|
Netherlands | €41.06 Billion |
|
CSL LTD SPON.ADR 2
F:CSJA
|
Germany | €17.90 Billion |
|
JD.com Inc Adr
NASDAQ:JD
|
USA | $401.67 Billion |
|
Block, Inc
NYSE:XYZ
|
USA | $18.31 Billion |
|
ArcelorMittal SA
XETRA:ARRD
|
Germany | €41.06 Billion |
|
Hyundai Mobis Co.,Ltd
KO:012330
|
Korea | ₩21.19 Trillion |
|
ArcelorMittal SA
MC:MTS
|
Spain | €41.06 Billion |
Liability Composition Analysis (1985–2025)
This chart breaks down Becton Dickinson and Company's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Becton Dickinson and Company (BDX) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Becton Dickinson and Company's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Becton Dickinson and Company (1985–2025)
The table below shows the annual total liabilities of Becton Dickinson and Company from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $29.94 Billion | -4.65% |
| 2024-09-30 | $31.40 Billion | +16.36% |
| 2023-09-30 | $26.98 Billion | -2.42% |
| 2022-09-30 | $27.65 Billion | -8.45% |
| 2021-09-30 | $30.20 Billion | -0.15% |
| 2020-09-30 | $30.25 Billion | -1.42% |
| 2019-09-30 | $30.68 Billion | -6.77% |
| 2018-09-30 | $32.91 Billion | +32.78% |
| 2017-09-30 | $24.79 Billion | +38.07% |
| 2016-09-30 | $17.95 Billion | -7.05% |
| 2015-09-30 | $19.31 Billion | +161.20% |
| 2014-09-30 | $7.39 Billion | +4.04% |
| 2013-09-30 | $7.11 Billion | -1.63% |
| 2012-09-30 | $7.22 Billion | +28.97% |
| 2011-09-30 | $5.60 Billion | +32.88% |
| 2010-09-30 | $4.22 Billion | +1.30% |
| 2009-09-30 | $4.16 Billion | +39.78% |
| 2008-09-30 | $2.98 Billion | +0.34% |
| 2007-09-30 | $2.97 Billion | -0.70% |
| 2006-09-30 | $2.99 Billion | +4.90% |
| 2005-09-30 | $2.85 Billion | +6.11% |
| 2004-09-30 | $2.68 Billion | +0.35% |
| 2003-09-30 | $2.68 Billion | +4.81% |
| 2002-09-30 | $2.55 Billion | +3.19% |
| 2001-09-30 | $2.47 Billion | -2.96% |
| 2000-09-30 | $2.55 Billion | -4.47% |
| 1999-09-30 | $2.67 Billion | +19.54% |
| 1998-09-30 | $2.23 Billion | +31.70% |
| 1997-09-30 | $1.69 Billion | +8.33% |
| 1996-09-30 | $1.56 Billion | -2.28% |
| 1995-09-30 | $1.60 Billion | -4.57% |
| 1994-09-30 | $1.68 Billion | +2.89% |
| 1993-09-30 | $1.63 Billion | +3.03% |
| 1992-09-30 | $1.58 Billion | +11.76% |
| 1991-09-30 | $1.42 Billion | +4.14% |
| 1990-09-30 | $1.36 Billion | +13.46% |
| 1989-09-30 | $1.20 Billion | +8.21% |
| 1988-09-30 | $1.11 Billion | +7.52% |
| 1987-09-30 | $1.03 Billion | +16.14% |
| 1986-09-30 | $887.00 Million | +58.45% |
| 1985-09-30 | $559.80 Million | -- |
About Becton Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segme… Read more